FDA Updates Label for Controversial Alzheimer’s Drug Aduhelm
https://www.medscape.com/viewarticle/954403?src=wnl_newsalrt_210708_MSCPEDIT&uac=17637FN&impID=3493826&faf=1
https://www.medscape.com/viewarticle/954403?src=wnl_newsalrt_210708_MSCPEDIT&uac=17637FN&impID=3493826&faf=1
https://www.statnews.com/2021/05/30/if-the-fda-approves-biogens-alzheimers-treatment-i-wont-prescribe-it/
https://www.medpagetoday.com/opinion/skeptical-cardiologist/81061 With the advent of the newer oral anticoagulants (NOACs) in the last decade that offer better stroke reduction and less bleeding than warfarin, patient-physician discussions should be about taking…
https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html?smid=fb-nytimes&smtyp=cur
https://www.statnews.com/2021/06/07/faqs-what-you-need-to-know-about-the-alzheimers-drug-aduhelm/?utm_campaign=rss Alzheimer’s drug controversy -aducanumab (Aduhelm) Decent summary can be found here –> F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works (msn.com) Patient information – It’s a…
https://drive.google.com/file/d/1CoVbVnd5X6EiJCJGjv2LaLvmYTJe-r9m/view
https://jamanetwork.com/journals/jama/fullarticle/2780202?resultClick=1
https://pubmed.ncbi.nlm.nih.gov/24436458/
https://www.sciencealert.com/working-long-hours-is-killing-hundreds-of-thousands-of-people-who-study-finds